Publication: The expression of hydrogen sulfide-producing enzymes in primary and lung metastatic osteosarcoma
Authors
Gong, Lihua ; Sun, Xiaoqi ; Zhang, Ming ; Du, Junbao ; Ding, Yi ; Jin, Hongfang
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia, Departamento de Biologia Celular e Histiologia
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-438
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Background. Hydrogen sulfide (H2S) is a
novel gas transmitter signaling molecule. H2S is
synthesized by cystathionine β-synthase (CBS),
cystathionine γ-lyase (CSE), and 3-mercaptopyruvate
sulfurtransferase (MST). There have been no reports
about the roles of these enzymes in osteosarcoma and its
metastases. We detected H2S synthase expression levels
in human primary osteosarcoma and lung metastatic
osteosarcoma.
Methods. Immunohistochemistry was performed in
primary osteosarcoma (n=19), lung metastatic
osteosarcoma (n=11), osteoblastoma (n=10) and bony
callus (n=2). The expression of CBS, CSE, and MST
was defined as negative, moderately positive and
strongly positive.
Results. MST staining was moderately to strongly
positive in all cases. CSE staining was negative in 94.7%
(18/19) of primary osteosarcoma cases and 90.9%
(10/11) of lung metastatic osteosarcoma cases. CBS
staining was strongly positive in 68.4% (13/19) of
primary osteosarcoma cases, moderately positive in
15.8% (3/19) of cases, and negative in 15.8% (3/19) of
cases. In lung metastatic osteosarcoma, the proportions
of negative, moderately positive and strongly positive
cases were 63.6% (7/11), 18.2% (2/11) and 18.2%
(2/11), respectively.
Conclusions. CBS and CSE expression, especially
CSE expression, decreased in both primary
osteosarcoma and lung metastatic osteosarcoma, which
may suggest that CBS and CSE play roles in osteoblast
cell malignant transformation and osteosarcoma
progression. These enzymes could be used as new
prognostic assessment factors and may represent new
therapeutic targets for osteosarcoma and metastasis
prevention
publication.page.subject
Citation
Histology and Histopathology Vol. 37, nº7 (2022)
item.page.embargo
Ir a Estadísticas
Este ítem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/